Springstubb Brendan B 4
4 · Evolent Health, Inc. · Filed Mar 5, 2025
Insider Transaction Report
Form 4
Springstubb Brendan B
Director
Transactions
- Award
Class A Common Stock
2025-03-03+6,842→ 6,842 total - Purchase
Class A Common Stock
2025-03-04$8.75/sh+5,000$43,750→ 11,842 total
Footnotes (2)
- [F1]Represents restricted stock units granted to Mr. Springstubb pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan.
- [F2]Securities vest on the earlier of March 3, 2026, and the date of the Company's 2025 annual meeting, subject to the reporting person's continued service on the vesting date.